The future of metabolic syndrome and cardiovascular disease prevention: Polyhype or polyhope? Tales from the polyera

Hormone and Metabolic Research

Volumn 39, Issue 9, 2007, Pages 627-631

  Franco, O H ^a   Karnik, K ^a   Bonneux, L ^b  

^a UNILEVER RESEARCH   (United Kingdom)

^b NETHERLANDS INTERDISCIPLINARY DEMOGRAPHIC INSTITUTE   (Netherlands)

Author keywords

Cardiovascular disease; Cost effectiveness; Polyera; Polymeal; Polypill; Primary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; FOLIC ACID; STATIN;

ALMOND; CACAO; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DRUG EFFECT; DRUG SAFETY; EVIDENCE BASED MEDICINE; FISH; FOOD INTAKE; FRUIT; GARLIC; HUMAN; METABOLIC SYNDROME X; MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; UNSPECIFIED SIDE EFFECT; VEGETABLE; WINE;

ANTIHYPERTENSIVE AGENTS; ASPIRIN; CARDIOVASCULAR DISEASES; DRUG COMBINATIONS; DRUG INCOMPATIBILITY; FOLIC ACID; FOOD; HUMANS; METABOLIC SYNDROME X; MODELS, THEORETICAL; QUALITY OF LIFE;

ALLIUM SATIVUM;

EID: 34848884283     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985814     Document Type: Conference Paper

References (40)

1. Faergeman O. The societal context of coronary artery disease. Eur Heart J 2005; 7 (Suppl A): A5-A11
2. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419
3. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438
4. WHO. The World Health Report: 2003: shaping the future. Geneve: World Health Organization, 2003
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
6. Rennie KL, MacCarthy N, Yazdgerdi S, Marmot M, Brunner E. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol 2003; 32: 600-606
7. Jacobson TA. Clinical context: current concepts of coronary heart disease management. Am J Med 2001; 110 (Suppl 6A): 3S-11S
8. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1423
9. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003; 326: 1427
10. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202
11. Franco OH, Steyerberg EW, de LC. The polypill: at what price would it become cost effective? J Epidemiol Community Health 2006; 60: 213-217
12. Farmacotherapeutisch Kompas : medisch farmaceuthische voorlichting/uitgave van de Commissie Farmaceuthische hulp van het College voor zorgverzerkeringen. Amstelveen: 2003
13. Euro-medicines. www.euromedicines.org. 2001
14. Gezondheidszorg CT. www.ctgzorg.nl. 2004
15. Franco OH, Bonneux L, de LC, Peeters A, Steyerberg EW, Mackenbach JP. The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 2004; 329: 1447-1450
16. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001; 161: 813-824
17. Castelnuovo A Di, Rotondo S, Iacoviello L, Donati MB, Gaetano G De. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002; 105: 2836-2844
18. Jenkins DJ, Kendall CW, Marchie A, Parker TL, Connelly PW, Qian W et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 2002; 106: 1327-1332
19. John JH, Ziebland S, Yudkin P, Roe LS, Neil HA. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002; 359: 1969-1974
20. Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr 2003; 77: 1379-1384
21. Taubert D, Berkels R, Roesen R, Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 2003; 290: 1029-1030
22. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004; 93: 1119-1123
23. Esmaillzadeh A, Kimiagar M, Maehrabi Y, Azadbakht L, Hu FB, Willett WC. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 2006; 84: 1489-1497
24. Baxter AJ, Coyne T, MacClintock C. Dietary patterns and metabolic syndrome-a review of epidemiologic evidence. Asia Pac J Clin Nutr 2006; 15: 134-142
25. Naissides M, Mamo JC, James AP, Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis 2006; 185: 438-445
26. Urquiaga I, Guasch V, Marshall G, San MA, Castillo O, Rozowski J et al. Effect of Mediterranean and Occidental diets, and red wine, on plasma fatty acids in humans. An intervention study. Biol Res 2004; 37: 253-261
27. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005; 46: 398-405
28. Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005; 81: 611-614
29. Vinson JA, Proch J, Bose P, Muchler S, Taffera P, Shuta D et al. Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets. J Agric Food Chem 2006; 54: 8071-8076
30. Mursu J, Voutilainen S, Nurmi T, Rissanen TH, Virtanen JK, Kaikkonen J et al. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med 2004; 37: 1351-1359
31. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 2001; 74: 596-602
32. Mukuddem-Petersen J, Oosthuizen W, Jerling JC. A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 2005; 135: 2082-2089
33. Josse AR, Kendall CW, Augustin LS, Ellis PR, Jenkins DJ. Almonds and postprandial glycemia-a dose-response study. Metabolism 2007; 56: 400-404
34. Jenkins DJ, Kendall CW, Josse AR, Salvatore S, Brighenti F, Augustin LS et al. Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr 2006; 136: 2987-2992
35. Mahmoodi M, Islami MR, sadi Karam GR, Khaksari M, Sahebghadam LA, Hajizadeh MR et al. Study of the effects of raw garlic consumption on the level of lipids and other blood biochemical factors in hyperlipidemic individuals. Pak J Pharm Sci 2006; 19: 295-298
36. Ashraf R, Aamir K, Shaikh AR, Ahmed T. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J Ayub Med Coll Abbottabad 2005; 17: 60-64
37. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189: 19-30
38. Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study. Diabetes Care 1994; 17: 37-44
39. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 279-286
40. Robinson JG, Maheshwari N. A"poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years. Am J Cardiol 2005; 95: 373-378